|
|
|
|
Vol. 57, Issue 3, 610-618, March 2000
Institut für Klinische Chemie und Pathobiochemie der
Justus-Liebig-Universität Gie
en, Gie
en (S.I., V.H., N.K.);
and Institut für Biochemie und Molekulare Zellbiologie der
Georg-August-Universität Göttingen, Göttingen,
Germany (T.K.)
| |
Abstract |
|---|
|
|
|---|
Heme oxygenase (HO) catalyzes the rate-limiting enzymatic step of heme
degradation and regulates the cellular heme content. The gene
expression of the inducible isoform of HO, HO-1, is up-regulated in
response to various agents causing oxidative stress. To investigate the
regulatory role of protein phosphatases in the hepatic regulation of
HO-1 gene expression, primary cultures of rat hepatocytes were treated
with okadaic acid (OA), which specifically inhibits the serine
threonine protein phosphatases 1 and 2A. Both protein synthesis and
mRNA expression of HO-1 were induced by OA in cultured hepatocytes, but
not in cultured tissue macrophages of rat liver. The HO-1 mRNA
induction by OA occurred in a time- and concentration-dependent manner.
Simultaneous treatment with OA plus dibutyryl cAMP caused a synergistic
up-regulation of steady-state levels of HO-1 mRNA, and the specific
protein kinase A inhibitor KT5720 markedly reduced the OA-dependent
HO-1 mRNA induction. In contrast, the dibutyryl cAMP-dependent
induction of the phosphoenolpyruvate carboxykinase mRNA expression and
enzyme activity was inhibited by simultaneous treatment with OA in
hepatocytes. The induction of the HO-1 gene expression by OA was
transcriptional as determined by studies with actinomycin D, nuclear
run-off assay, and measurement of the half-life of HO-1 mRNA.
Luciferase reporter constructs containing DNA sequences of the rat HO-1
promoter 5'-flanking region were up-regulated by OA in transiently
transfected hepatocytes. Mutation of the cAMP response
element/activator protein-1 (
665/
654) site obliterated the
OA-dependent induction, suggesting that this element is involved in the
transcriptional induction of the rat HO-1 gene by OA.
| |
Introduction |
|---|
|
|
|---|
Heme
oxygenase (HO) catalyzes the first and rate-limiting step of heme
degradation and controls the cellular heme availability (Tenhunen et
al., 1968
). HO enzymatically breaks down the pro-oxidant heme,
producing equimolar amounts of carbon monoxide, iron, and biliverdin,
which are converted by biliverdin reductase into the antioxidant
bilirubin (Stocker et al., 1987
). At least two distinct isoforms of HO
are known that are the products of different genes. In contrast to the
constitutive isozyme HO-2 (Maines et al., 1986
), HO-1 is the inducible
isozyme, which is highly up-regulated by various stress stimuli
including its substrate heme, heavy metals, UV light,
lipopolysaccharide, heat shock, and hyperoxia (Shibahara et al., 1987
;
Applegate et al., 1991
; for reviews see Maines, 1988
, and Choi and
Alam, 1996
). Although the exact functional role of HO-1 induction is
not fully understood, various researchers have shown that HO-1 provides
protection against oxidative stress in various cell culture and in in
vivo models (Abraham et al., 1995
; Lee et al., 1996
). Overexpression of
the HO-1 gene attenuates the toxic effects of heme proteins in coronary
endothelial cells (Abraham et al., 1995
) and protects pulmonary
epithelial cells against hyperoxia (Lee et al., 1996
). Poss and
Tonegawa (1997a)
have shown that HO-1-deficient mice develop an anemia
with abnormally low serum iron levels, along with an overload of iron
in liver and kidney, causing oxidative damage and chronic inflammation. In addition, HO-1-deficient mice were highly susceptible to
endotoxin-mediated hepatic damage, resulting in a higher mortality rate
from endotoxic shock in these animals (Poss and Tonegawa, 1997b
).
OA is a polyether fatty acid isolated from marine sponges that
initially has been shown to be a tumor promoter (Holmes and Boland,
1993
). Instead of activating protein kinase (PK) C as do phorbol ester
tumor promoters, OA is a specific inhibitor of protein phosphatase
(PP)1 and PP2A (Holmes and Boland, 1993
). PP1 and PP2A dephosphorylate
serine and threonine residues in cellular target proteins that are
involved in the regulation of multiple signaling pathways (for review,
see Wera and Hemmings, 1995
). Induction of HO-1 gene expression by
activation of PKC (Muraosa and Shibahara, 1993
), cAMP-dependent PK
(PKA) (Durante et al., 1997
; Immenschuh et al., 1998b
), or
cGMP-dependent PK (PKG) (Immenschuh et al., 1998a
) has been
demonstrated previously; however, little is known about the role of PPs
in the gene regulation of HO-1. Because it has become increasingly
obvious that PPs play a major role in maintaining the intracellular
balance of gene expression (Hunter, 1995
), we investigated the effects
of OA on the expression of the HO-1 gene in cultures of primary rat hepatocytes.
In this study, it is shown that OA induces HO-1 gene expression on the protein and mRNA level in a time- and dose-dependent manner. This induction of HO-1 by OA is regulated on the transcriptional level and appears to be mediated by the cAMP response element (CRE)/AP-1 site of the rat HO-1 gene promoter 5'-flanking region.
| |
Experimental Procedures |
|---|
|
|
|---|
Animals. Male Wistar rats (2 months old, body weight 170-200 g) were used throughout the study.
Materials. Media M199 and RPMI were obtained from Life Technologies (Karlsruhe, Germany), nitrocellulose filters were from Schleicher and Schuell (Dassel, Germany), and radioisotopes and the chemiluminescent detection system for Western blotting were from Amersham-Buchler (Braunschweig, Germany). The multiprime labeling kit and restriction endonucleases were from New England Biolabs (Cambridge, MA). Falcon tissue culture dishes were from Becton Dickinson (Heidelberg, Germany). OA, calyculin A, and KT5720 were from Calbiochem (San Diego, CA). The polyclonal rabbit anti-rat HO-1 antibody was obtained from Stress Gene (Victoria, Canada). All other chemicals were obtained from Sigma (Deisenhofen, Germany) and Boehringer Mannheim (Mannheim, Germany) unless indicated otherwise.
Cell Isolation and Culture.
Hepatocytes were isolated from
male Wistar rats by circulating perfusion with collagenase under
sterile conditions as described previously (Immenschuh et al., 1998b
).
The cells were cultured under air/CO2 (19/1) in
medium 199 with Earle's salts containing 2 g/l BSA, 20 mM
NaHCO3, 10 mM HEPES, 117 mg/l streptomycin
sulfate, 60 mg/l penicillin, 1 nM insulin, and 10 nM dexamethasone.
Fetal calf serum (5%) was present during the plating phase up to
4 h, and cell cultures were incubated in serum-free medium for
another 18 h before treatment. Hepa 1-6 and NIH3T3 cells were
from the American Type Culture Collection (Manassas, VA). Hepa 1-6
cells were cultured in RPMI 1640 medium containing 2% fetal calf
serum, and NIH3T3 cells were cultured in DMEM with 10% fetal calf
serum until confluency of cell monolayers was reached. Confluent
monolayers were incubated in serum-free medium 18 h before treatment.
Biosynthetic Labeling, Immunoprecipitation, and
SDS-Polyacrylamide Gel Electrophoresis (PAGE) of Synthesized
Proteins.
Hepatocytes were washed with methionine-free M199 and
were pulsed for 2 h with M199 containing
[5S]methionine (600 µCi/ml). Cell layers were
washed with ice-cold PBS, covered with lysis buffer (PBS, 0.5%;
deoxycholic acid, 1g%; SDS, 7.4%) containing 1 mM
phenylmethylsulfonyl fluoride (PMSF) and were frozen at
70°C. After
two freezing/thawing cycles in lysis buffer, lysates were centrifuged
(10,000g, 30 min, 4°C) and diluted with lysis buffer
(1:1). For immunoprecipitation, samples adjusted to contain equal
amounts of radioactivity, as determined by trichloroacetic acid
precipitation and
-ray counting, were incubated overnight with an
excess of antiserum at 4°C. Subsequently, samples were incubated with
Pansorbin for 1 h, and the precipitates were washed with lysis
buffer and analyzed using SDS-PAGE (15% acrylamide).
Western Blot Analysis. Total protein was prepared from whole liver or cultured hepatocytes by the addition of 1 ml of boiling lysis buffer (0.1% SDS, 10 mM Tris, pH 7.4) and subsequent sonication of liver or scraping of the cells. Cells then were boiled for 5 min and homogenized by passing through a 25-gauge needle. The homogenate was centrifuged for 5 min at 4°C, and the protein content was determined in the supernatant using the Bradford method. Total protein (40 µg) was loaded onto a 10% SDS-polyacrylamide gel and blotted onto nitrocellulose membranes by electrophoresis. Membranes were blocked with Tris-buffered saline containing 1% BSA, 10 mM Tris/HCl (pH 7.5), and 0.1% Tween 20, for 1 h at room temperature. The primary antibody for HO-1 was added in a 1:1000 dilution, and the blot was incubated for 12 h at 4°C. The enhanced chemiluminescent detection system was used for detection.
RNA Isolation, Northern Blot Analysis, and Hybridization.
Total RNA for Northern blotting from hepatocytes, Kupffer cells, or
whole liver was isolated as described (Immenschuh et al., 1998b
, 1999
).
Equal quantities of RNA were separated on 1.2% agarose, 2.2 M
formaldehyde gels. After electrophoresis, RNA was blotted onto
nitrocellulose membranes and baked at 80°C for 4 h. After prehybridization for 4 h at 42°C, blots were hybridized
overnight with [
-32P]dCTP-radiolabeled cDNA
probes at 42°C or a 28S rRNA oligonucleotide as described previously
(Immenschuh et al., 1999
). The hybridization solution contained 6×
standard saline citrate; 5× Denhardt's solution (0.2% Ficoll 400, 0.2% polyvinyl pyrrolidone, and 0.2% BSA); 0.5% SDS; 50% formamide;
and 100 µg/ml denatured salmon sperm DNA. Blots were washed
subsequently with 2× SSC/0.1% SDS (once) and 0.1× SSC/0.1% SDS
(twice) at 65°C. Filters were autoradiographed with X-ray films
(X-OMAT RP, Kodak; Rochester, NY) at
70°C for up to 48 h or
stored on a phosphorimager screen for 4 to 8 h. Autoradiograms
were quantified with phosphorimager running Imagequant software
(Molecular Dynamics, Sunnyvale, CA). When nitrocellulose filters were
sequentially hybridized with different cDNA probes, the
32P-labeled cDNA was removed after
autoradiography by two washing steps with boiling 0.05× SSC/0.1% SDS
for 15 min before rehybridization.
cDNA Probes.
The probes were the cDNAs of HO-1,
phosphoenolpyruvate carboxykinase (PCK), and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) of rat (Immenschuh et al., 1998b
). The
cDNAs were labeled by the oligomer method with
[
-32P]dCTP using the multiprime DNA labeling
kit according to the manufacturer's instructions.
Isolation of Nuclei from Rat Hepatocyte Cultures. Approximately 1 × 107 cells from primary rat hepatocyte cultures were washed twice with ice-cold 320 mM sucrose, 3 mM CaCl2, 2 mM magnesium acetate, 100 µM EDTA, 100 µM PMSF, 150 µM spermine, 500 µM spermidine, 1 mM dithioerythritol, and 10 mM Tris/HCl, pH 8.0 (buffer A). The cells were scraped off the dishes into buffer A and homogenized in a 2-ml Dounce homogenizer at 4°C. After addition of 4 ml of buffer A, the nuclei were pelleted by centrifugation at 300g for 5 min. The pellets were resuspended in 0.4 ml of buffer A, and the suspension was mixed with 1.6 ml 2 M sucrose, 5 mM magnesium acetate, 100 µM EDTA, 100 µM PMSF, 150 µM spermine, 500 µM spermidine, 1 mM dithioerythritol, and 10 mM Tris/HCl, pH 8.0 (buffer B). This suspension was layered onto a cushion of 2 ml of buffer B and pelleted for 1 h in a Beckman SW60 rotor at 20,000 rpm at 4°C. The pelleted nuclei were suspended in 25 ml of 25% glycerol, 5 mM magnesium acetate, 100 µM EDTA, 100 µM PMSF, 5 mM dithioerythritol, and 50 mM Tris/HCl, pH 8.0 (buffer C).
Nuclear Run-Off Transcription Assay.
The nuclear run-off
reaction was performed with 2 × 106 nuclei
in a volume of 20 µl as described (Immenschuh et al., 1998b
). The in
vitro transcription reaction was started by the addition of 30 ml of
58% glycerol, 150 mM NH4Cl, 8.3 mM
MgCl2, 830 µM MnCl2, 70 µM EDTA, 25 U of ribonuclease inhibitor, 830 µM ATP, 830 µM CTP,
830 µM GTP, 100 µCi [32P]UTP, and 33 mM
HEPES, pH 8.0 (solution D). After incubation of nuclei for 30 min at
37°C, the reaction was stopped by the addition of EDTA.
Plasmid Constructs.
The rat HO-1 promoter 5'-flanking region
from
1338 to +71 was amplified by PCR from rat genomic DNA by using
the oligonucleotide 5'-CTCAGGATTAACAAAACAAAGACACAAAAAG-3'
(
1338/
1309) as forward and 5'-GAGATGGCTCTGCTCCGGCAGGCTCCACTC-3'
(+42/+71) as reverse primer, respectively. The resulting PCR product
was blunted by Klenow enzyme and phosphorylated with T4 polynucleotide
kinase and ligated into the SmaI site of pUC18. The insert
was excised with KpnI/BamHI and cloned into the
KpnI/BglII site of pGl3basic (Promega, Madison,
WI) (pHO-1338 Luc; see Fig. 7, construct 1). Construction of plasmid
pHO-754 Luc (see Fig. 7, construct 2), mutated rat HO-1 gene promoter
constructs (see Fig. 7, pHO-754del, construct 3; and pHO
CRE/AP-1,
construct 4), and chloramphenicol acetyltransferase (CAT) construct
pPCK-2500 CAT has been described previously in detail (Immenschuh et
al., 1998a
, Bratke et al., 1999
). All constructs were verified by
sequencing in both directions.
Cell Transfection, Luciferase, and CAT Assay.
Rat hepatocyte
cultures (~1 × 106 cells per dish) were
transfected transiently with 2.5 µg of plasmid DNA containing 500 ng of pRL-SV40 (Promega) to control transfection efficiency and 2 µg of
the HO-1 promoter luciferase construct (Immenschuh et al., 1998a
).
Luciferase and CAT activity were determined as described previously
(Immenschuh et al., 1998a
; Bratke et al., 1999
).
PCK Enzyme Activity.
PCK enzyme activity was determined in
duplicate as described previously (Bratke et al., 1999
).
| |
Results |
|---|
|
|
|---|
OA-Dependent Induction of HO-1 Gene Expression in Cultures of
Primary Rat Hepatocytes.
To study the effect of the PP inhibitor
OA on the synthesis of HO-1, newly synthesized proteins were
pulse-labeled with [35S]methionine in primary
rat hepatocytes treated with OA at various concentrations, and HO-1
protein was immunoprecipitated from cell lysates. As shown in Fig.
1A, HO-1 protein was dose dependently up-regulated in the presence of OA. Next, we determined the effect of
OA on steady-state levels of HO-1 mRNA. HO-1 message was markedly induced in hepatocyte cultures after 6 h (Fig. 1B). For
comparison, no up-regulation of HO-1 mRNA expression by OA was observed
in cultured rat liver tissue macrophages (Kupffer cells; Fig. 1C). The
induction of HO-1 mRNA expression by heme, which is one of the most
effective inducers of this enzyme, is shown as a positive control in
Kupffer cells (Fig. 1C, lane 4). In two hepatoma cell lines (H35 and
Hepa 1-6) and NIH3T3 fibroblasts, treatment with OA had no effect on
HO-1 mRNA steady-state levels (data not shown). Because HO-1 activity
has been shown to be increased during the first days of cell culture of
primary rat hepatocytes (Schuetz et al., 1988
), we compared HO-1 gene
expression in our system of hepatocyte cultures with that in whole
liver. Both the expression of HO-1 protein and mRNA were higher
in 24-h cultured rat hepatocytes compared with that in whole liver
(Fig. 1D). Thereafter, HO-1 mRNA and protein declined and reached
approximately the level of whole liver after 72 h of cell culture.
To exclude the possibility that OA augments the effect of a stimulating
factor, which may be generated during the isolation of rat hepatocytes,
rather than stimulating the HO-1 gene expression per se, hepatocytes
also were treated with OA after 120 h of cell culture. The
OA-dependent induction of HO-1 gene expression in these long-term
cultured hepatocytes was 14- ± 1.5-fold (n = 3)
on the mRNA level and 4- ± 0.6-fold (n = 3) on the
protein level (data not shown).
|
|
|
Differential Effects of OA on the Bt2cAMP-Dependent
Induction of HO-1 and PCK Gene Expression.
Because HO-1 gene
expression is induced by activation of PKA in primary rat hepatocyte
cultures (Immenschuh et al., 1998b
) and OA has been shown to augment
the transcriptional response to cAMP (Hagiwara et al., 1992
),
hepatocytes were treated with the specific inhibitor of PKA, KT5720,
before OA was added for another 6 h. As shown in Fig.
3A, pretreatment with KT5720 reduced the
OA-dependent HO-1 mRNA induction by >50%. Moreover, simultaneous treatment of hepatocytes with Bt2cAMP and OA at
submaximal doses caused a synergistic induction of HO-1 mRNA expression
(Fig. 3B). To investigate the putative cross-talk of OA with the PKA
signaling pathway, we also examined the effect of OA on the expression
of the PCK gene, which is a liver-specific, cAMP-induced gene. PCK catalyzes the rate-controlling step of the gluconeogenic pathway and is
induced by a variety of stimuli enhancing intracellular cAMP levels
(for review, see Hanson and Reshef, 1997
). In contrast to the
OA-dependent regulation of HO-1 gene expression, OA on its own did not
affect basal PCK mRNA expression or enzyme activity (Fig.
4). Simultaneous treatment of
Bt2cAMP-treated hepatocytes with OA reduced the
PCK mRNA expression and enzyme activity elicited by
Bt2cAMP dose dependently (Fig. 4). These findings
on the PCK gene expression are in agreement with those from a previous
report in H4IIE rat hepatoma cells (O'Brien et al., 1994
). Therefore, OA may affect the PKA signaling pathway in primary rat hepatocytes; however, it may result in differential regulation of cAMP-activated gene expression.
|
|
Transcriptional Induction of HO-1 Gene Expression by OA.
Up-regulation of the HO-1 gene occurs on the transcriptional level by
most stimuli (Shibahara et al., 1987
; Choi and Alam, 1996
; Durante et
al., 1997
; Immenschuh et al., 1998b
). To probe into the mechanism of
the OA-dependent HO-1 gene induction, hepatocyte cultures were treated
with the transcription inhibitor actinomycin D (ActD) and the protein
synthesis inhibitor cycloheximide (CHX). Both agents were added at a
concentration of 1 µg/ml for 30 min before OA was added for another
6 h. Neither ActD nor CHX alone had an effect on the basal
HO-1 mRNA expression, respectively (Fig.
5A). ActD prevented the OA-dependent HO-1
mRNA induction. CHX reduced the OA-elicited HO-1 mRNA expression levels
by 50% (Fig. 5A). Because the data indicated a transcriptional mode of induction, nuclear run-off assays were performed with nuclei from OA-treated hepatocyte cultures. The transcription rate of the HO-1 gene
was strongly increased by OA (Fig. 5B). The turnover rate of HO-1 mRNA
was determined in cell cultures after exposure to OA. As shown in Fig.
6, the half-life of HO-1 mRNA was
slightly decreased during treatment with OA (4.7 h versus 4.2 h).
|
|
OA-Dependent Induction of the Rat HO-1 Gene Promoter in Transiently
Transfected Rat Hepatocyte Cultures.
To investigate whether
regulatory elements of the rat HO-1 5'-flanking promoter region are
involved in the transcriptional regulation by OA, luciferase reporter
constructs containing either the proximal 1338 or the 754 base pairs of
the rat HO-1 promoter region were transiently transfected into primary
rat hepatocyte cultures (Fig. 7,
constructs 1 and 2; Table 2, pHO-1338 Luc
and pHO-754 Luc). OA up-regulated the luciferase expression of these constructs 4- and 5.5-fold, respectively (Fig. 7), and a combination of
submaximal doses of OA plus Bt2cAMP induced
luciferase expression additively (Table 2). An HO-1 reporter construct
with a deletion from
714 to
549 (Fig. 7, construct 3) and a
construct lacking the CRE/AP-1 site (Fig. 7, construct 4) were not
regulated by OA (Fig. 7). For a comparison, the regulation of a CAT
reporter construct containing 2500 base pairs of the rat PCK promoter
5'-flanking region was examined in transfected rat hepatocytes (Table
2). Whereas treatment with OA alone had no effect, the
Bt2cAMP-dependent induction of this reporter
construct was inhibited by OA (Table 2, pPCK-2500 CAT).
|
|
| |
Discussion |
|---|
|
|
|---|
In this study, it is shown in cultured rat hepatocytes that the serine threonine PP inhibitor OA up-regulates the gene expression of HO-1, which is the inducible enzyme of heme degradation. The OA-dependent HO-1 induction occurs on the transcriptional level and is mediated by a DNA sequence of the HO-1 gene promoter 5'-flanking region.
The OA-dependent increase of HO-1 gene expression is primarily
regulated on the transcriptional level, as demonstrated by blocking of
the HO-1 mRNA induction with ActD (Fig. 5A), nuclear run-off assay
(Fig. 5B), and transfection of HO-1 reporter gene constructs into
hepatocyte cultures (Fig. 7). Stabilization of HO-1 message is not
involved in the OA-dependent HO-1 gene regulation (Fig. 6), but protein
synthesis de novo appears to contribute to this induction, as indicated
by the inhibition of OA-dependent HO-1 mRNA expression by CHX (Fig. 5A)
suggesting that protein(s) with a short half-life participate(s) in
this regulatory pathway. Therefore, OA adds to the various stimuli that
modulate the transcription rate of the HO-1 gene (Shibahara et al.,
1987
; Applegate et al., 1991
; Durante et al., 1997
; for review, see
Choi and Alam, 1996
). Several REs within the promoter
5'-flanking region that are involved in the activation of the human,
mouse, and rat HO-1 genes have been characterized (for review, see Choi
and Alam, 1996
). As demonstrated by transient transfection of rat HO-1
gene reporter constructs into rat hepatocytes, the CRE/AP-1 element of
the rat HO-1 gene (position
665 to
654) (Immenschuh et al., 1998a
)
is involved in the OA-dependent regulation of the HO-1 gene (Fig. 7).
Although deletion of the HO-1 CRE/AP-1 element abolished the
OA-dependent induction of luciferase reporter gene activity, it cannot
be excluded that additional REs are involved in the OA-dependent
gene regulation. A potential transcription factor (TF) that may mediate
the OA-dependent transcriptional induction is the CRE-binding protein
(CREB), which is activated on phosphorylation at Ser-133. Hagiwara et
al. (1992)
have demonstrated that OA inhibits the dephosphorylation of
the Ser-133 of phospho-CREB, thereby augmenting cAMP-dependent gene expression. The hypothesis that CREB may mediate the OA-dependent HO-1
induction is supported by the observations that OA and
Bt2cAMP elicit a synergistic effect on HO-1 mRNA
up-regulation and that the specific PKA inhibitor KT5720 reduces the
induction of HO-1 mRNA expression by OA (Fig. 3). Moreover, the
pHO-1338 Luc and pHO-754 Luc HO-1 gene reporter constructs are
up-regulated additively by submaximal doses of OA and
Bt2cAMP (Table 2). Whether the Ser-133 of CREB is
dephosphorylated by PP1 or PP2A appears to be cell type-dependent.
Alberts et al. (1994)
have shown that PP1 is the major regulator of
dephosphorylation of CREB in fibroblasts. By contrast, others have
demonstrated in rat liver and HepG2 hepatoma cells that PP2A
dephosphorylates phospho-CREB 30-fold more efficiently than does PP1
(Wadzinski et al., 1993
). The latter finding would correlate with our
observation that OA, but not calyculin A, induced HO-1 gene expression
in rat hepatocyte cultures at the applied concentrations (Table 1). OA
has been reported to inhibit PP2A ~5- to 10-fold stronger than does
calyculin A, whereas calyculin A is a significantly stronger inhibitor
of PP1 than OA (Holmes and Boland, 1993
). In contradiction to the idea
that CREB may mediate the OA-dependent HO-1 induction on its own is the
inhibitory effect of OA on the cAMP-dependent PCK gene expression. The
cAMP-dependent induction of the PCK gene is known to be primarily
mediated via a CRE (Hanson and Reshef, 1997
); however, in our system of
primary rat hepatocyte cultures, the cAMP-dependent induction of the
PCK gene was inhibited by OA (Fig. 4, Table 2), as similarly reported in H4IIE hepatoma cells (O'Brien et al., 1994
). It also has been shown
that the liver-specific induction of the PCK gene promoter requires
synergism of the TFs CREB and C/EBP
to mediate the full cAMP
response in hepatic cells (Roesler et al., 1996
). Other TFs that have
been demonstrated to be involved in the OA-dependent gene expression
are NF
B and AP-1. NF
B has been reported to be activated by OA via
phosphorylation and subsequent degradation of I
B (Sun et al., 1995
),
and increased binding of AP-1 to its recognition sequence by OA has
been demonstrated in Syrian hamster hepatocytes (Tohkin et al., 1996
)
and in a mouse keratinocyte cell line (Rosenberger and Bowden, 1996
).
What are the signaling pathways that are involved in the HO-1 gene
regulation by OA? HO-1 mRNA induction by OA was observed in rat
hepatocytes, but not in cell cultures such as liver tissue macrophages
(Fig. 1C), which exhibit a high basal level of HO-1 gene expression
(Bauer et al., 1998
; Immenschuh et al., 1999
), or in NIH3T3 fibroblasts
(data not shown), suggesting a hepatocyte-specific signaling pathway.
The data correspond with a previous study showing that the
PKA-dependent induction of HO-1 is specific in primary rat hepatocyte
cultures (Immenschuh et al., 1998b
). Similar findings have been
reported for the inducible nitric-oxide synthase (iNOS) by Pahan et al.
(1998)
, who have demonstrated contrasting effects of OA on the
expression of iNOS in rat astrocyte and macrophage cell cultures.
Because PP2A is known to deactivate the extracellular signal-regulated
kinases (ERK) 1/2 (Hunter, 1995
), it is conceivable that the
inhibition of PP2A by OA may activate these mitogen-activated PKs. In
fact, it has been shown recently that ERK 1/2 participate in the
OA-dependent transcriptional induction of the human collagenase gene
via AP-1 activation in mouse keratinocytes (Rosenberger et al., 1999
).
As to the role of ERKs in the induction of HO-1 gene expression by
stress inducers, the available data are not conclusive. Elbirt et al.
(1998)
have reported that for chicken HO-1 gene promoter constructs in
transiently transfected LMH chicken hepatoma cells, ERKs may be
involved in the regulation of HO-1 by sodium arsenite. By contrast,
Masuya et al. (1998)
have demonstrated that for the endogenous human
HO-1 gene expression in HeLa cells, tyrosine kinases rather than
mitogen-activated kinases, are involved in the regulation of HO-1 gene
expression by various stress inducers including sodium arsenite.
Because the cellular "free heme pool" of hepatocytes, e.g., the
nonprotein bound portion of heme in hepatocytes (Granick et al., 1975
),
is regulated via the enzymatic degradation by HO, the OA-dependent
induction of HO-1 expression may significantly decrease the cellular
heme availability in hepatocytes. A low "free heme pool," in turn,
could decrease the enzyme activity of the iNOS. Albakri and Stuehr
(1996)
have demonstrated that sufficient intracellular heme is
essential for the formation of dimeric iNOS and its catalytic activity.
HO-1 is thought to provide protection against oxidative stress, most
likely attributable to the fact that HO enzymatically degrades the
pro-oxidant heme leading to the formation of the antioxidant bilirubin
(Stocker et al., 1987
). This assumption is underscored by findings that HO-1 deficient mice are highly susceptible to the toxic effects of
oxidative stress (Poss and Tonegawa, 1997b
). Recently, the first case
of human HO-1 deficiency has been described (Yachie et al., 1999
),
showing characteristics similar to those observed in HO-1-deficient
mice (Poss and Tonegawa, 1997b
). The induction of HO-1 by the PP
inhibitor OA indicates that the balance between cellular kinases and
phosphatases is important for the regulation of HO-1 gene expression.
Additional studies to elucidate the detailed regulatory pathways of
HO-1 gene expression are necessary to develop strategies for a
potential targeted pharmacologic modulation of HO-1.
| |
Acknowledgments |
|---|
We thank Dr. S. Shibahara (Sendai, Japan) for providing rat HO-1 cDNA. We also thank Dr. J. Bratke for technical assistance and Dr. K. Jungermann for continuous support.
| |
Footnotes |
|---|
Received May 13, 1999; Accepted November 19, 1999
1 Present address: Zentrum Innere Medizin, Abteilung Gastroenterologie und Endokrinologie, Georg-August-Universität Göttingen, Robert Koch Str. 40, 37075 Göttingen; Germany.
This work was supported by grants from the Deutsche Forschungsgemeinschaft Im 2-1 (S.I.) and SFB 402 A1 (T.K.).
Send reprint requests to: Dr. Stephan Immenschuh, Zentrum Innere Medizin, Abteilung Gastroenterologie und Endokrinologie, Georg-August-Universität Göttingen, Robert-Koch-Str. 40, 37075 Göttingen, Germany. E-mail: simmens{at}gwdg.de
| |
Abbreviations |
|---|
HO, heme oxygenase; ActD, actinomycin D; AP-1, activator protein-1; Bt2cAMP, dibutyryl cAMP; CAT, chloramphenicol acetytransferase; CHX, cycloheximide; CRE, cAMP response element; CREB, CRE-binding protein; CYP, cytochrome P450; ERK, extracellular signal-regulated kinase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; iNOS, inducible nitric-oxide synthase; OA, okadaic acid; PCK, phosphoenolpyruvate carboxykinase; PK, protein kinase; PCR, polymerase chain reaction; PKA, cAMP-dependent protein kinase; PKG, cGMP-dependent protein kinase; PP, protein phosphatase; rRNA, ribosomal RNA; TF, transcription factor; PMSF, phenylmethylsulfonyl fluoride.
| |
References |
|---|
|
|
|---|
-isoform of the CCAAT/enhancer-binding protein is required for mediating cAMP responsiveness of the phosphoenolpyruvate carboxykinase promoter in hepatoma cells.
J Biol Chem
271:
8068-8074
B by phosphatase inhibitors involves the phosphorylation of I
B
at phosphatase 2A-sensitive sites.
J Biol Chem
270:
18347-18351This article has been cited by other articles:
![]() |
S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wijayanti, T. Kietzmann, and S. Immenschuh Heme Oxygenase-1 Gene Activation by the NAD(P)H Oxidase Inhibitor 4-(2-Aminoethyl) Benzenesulfonyl Fluoride via a Protein Kinase B, p38-dependent Signaling Pathway in Monocytes J. Biol. Chem., June 10, 2005; 280(23): 21820 - 21829. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Heinloth, R. D. Irwin, G. A. Boorman, P. Nettesheim, R. D. Fannin, S. O. Sieber, M. L. Snell, C. J. Tucker, L. Li, G. S. Travlos, et al. Gene Expression Profiling of Rat Livers Reveals Indicators of Potential Adverse Effects Toxicol. Sci., July 1, 2004; 80(1): 193 - 202. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sikorski, T. Hock, N. Hill-Kapturczak, and A. Agarwal The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury Am J Physiol Renal Physiol, March 1, 2004; 286(3): F425 - F441. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor Different Faces of the Heme-Heme Oxygenase System in Inflammation Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||